Rapid Detection of Mycobacterium tuberculosis Complex and Rifampin Resistance in Smear-Negative Clinical Samples by Use of an Integrated Real-Time PCR Method
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Sixty-four of 85 (75.3%) smear-negative respiratory ( n = 78) and nonrespiratory ( n = 7) samples with positive cultures of Mycobacterium tuberculosis complex (MTC) were detected by the GeneXpert system using the Xpert MTB/RIF assay (GX). In addition, GX found rpoB mutations in all six of the rifampin-resistant strains detected. The test was negative in 20 culture-negative and 20 nontuberculous culture-positive samples (100% specificity). GX offers high potential for the diagnosis of tuberculosis due to its capacity for direct detection of MTC, its rapidity, and its simplicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 2×
“Nonrespiratory specimens Pleural fluid (4) 2 2 Gastric aspirate (5) 2 3 Urine (2) 2 Stool (1) 1 Cerebrospinal fluid (3) 3 Ascitic fluid (2) 2 Lymph node aspirate (1) 1 Skin biopsy (1) 1 Mammary abscess (1) 1”
BackgroundMethodDetection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337 · cited 3×
“Isolates showing resistance to RIF were further analyzed by sequencing of an internal region of the rpoB gene, which included the rifampin resistance-determining region (RRDR), in order to identify mutations associated with phenotypic resistance (17).”
BackgroundMethodHelb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 1×
“A real-time automated integrated system, the GeneXpert system using the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA) (GX), has recently been developed and evaluated (2, 3, 10).”
MethodTransmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli
Behr, M., Warren, S., Salamon, H., Hopewell, P., de Leon, A. P., Daley, C., & Small, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03406-0 · Cited by 754 · cited 3×
“Respiratory specimens Sputum (92) 72 19 1 Bronchial aspirate (12) 5 1 6 Pulmonary biopsy (1) 1”
BackgroundAnti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection
Dinnes, J., Deeks, J., Kunst, H., Gibson, A., Cummins, E., Waugh, N., Drobniewski, F., & Lalvani, A. (2007) · Health Technology Assessment · doi:10.3310/hta11030 · Cited by 666
Evaluation of the analytical performance of the Xpert MTB/RIF assay
Blakemore, R., Story, E., Helb, D., Kop, J., Banada, P., Owens, M. R., Chakravorty, S., Jones, M., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-10 · Cited by 485 · cited 2×
“Nonrespiratory specimens Pleural fluid (4) 2 2 Gastric aspirate (5) 2 3 Urine (2) 2 Stool (1) 1 Cerebrospinal fluid (3) 3 Ascitic fluid (2) 2 Lymph node aspirate (1) 1 Skin biopsy (1) 1 Mammary abscess (1) 1”
BackgroundMethodMolecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis
Piatek, A. S., Tyagi, S., Pol, A. C., Telenti, A., Miller, L. P., Kramer, F. R., & Alland, D. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-359 · Cited by 419 · cited 1×
“The detection consists of the hybridization of the amplicon with five overlapping probes complementary to the rpoB “core” region (81 bp) determining the RIF resistance (9, 15, 17).”
MethodGlobal Tuberculosis Programme, & Disease, L. (1997) · Medical Entomology and Zoology · Cited by 361
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
(2009) · JAMA · doi:10.1001/jama.2009.148 · Cited by 268
Cited by
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Lawn, S. D., & Nicol, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.84 · Cited by 486
Zeka, A. N., Tasbakan, S., & Cavusoglu, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05434-11 · Cited by 362
Nicol, M. P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Boehme, C. C., Zemanay, W., & Zar, H. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70167-0 · Cited by 338
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
“There is a large number of studies evaluating Xpert on pulmonary specimens [5,6,17-23]; the sensibility varies from 95 to 100% in smear-positive sputa, and from 47 to 77% in smearnegative ones.”
BackgroundLawn, S. D., Brooks, S. V., Kranzer, K., Nicol, M. P., Whitelaw, A., Vogt, M., Bekker, L.-G., & Wood, R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001067 · Cited by 278
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
Horne, D. J., Kohli, M., Zifodya, J. S., Schiller, I., Dendukuri, N., Tollefson, D., Schumacher, S. G., Ochodo, E. A., Pai, M., & Steingart, K. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub4 · Cited by 267
Chang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., Deng, S., & Chen, M. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.02.012 · Cited by 267
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Weyer, K., Mirzayev, F., Migliori, G. B., Van Gemert, W., D'Ambrosio, L., Zignol, M., Floyd, K., Centis, R., Cirillo, D. M., Tortoli, E., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00157212 · Cited by 256
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Armand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02157-10 · Cited by 179
“In our study, the Xpert MTB/RIF test’s sensitivity with smear-negative respiratory specimens (57%) was found to be lower than that ( 72%) reported in recent studies performed with respiratory specimens (3, 9, 15, 16).”
BackgroundResultInfluentialRachow, A., Zumla, A., Heinrich, N., Rojas-Ponce, G., Mtafya, B., Reither, K., Ntinginya, E. N., O'Grady, J., Huggett, J., Dheda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020458 · Cited by 160
“The assay has recently undergone performance evaluation on respiratory specimens [9,10,11,12] as well as on non-respiratory samples [11] [13], one of them was a multi-country ‘technical’ evaluation which showed the Xpert MTB/RIF Assay to have high sensitivity and specificity [10], producing results in 2 hours.”
MethodClinical Aspects of Adult Tuberculosis
Loddenkemper, R., Lipman, M., & Zumla, A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017848 · Cited by 140
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0536oc · Cited by 118
Moure, R., Martín, R., & Alcaide, F. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06467-11 · Cited by 90
“Nevertheless, in light of previous reports (12), an association between the bacterial load (represented by the days required for growth) and the qualitative and semiquantitative results of the GX was found.”
BackgroundSelf-citationXpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistance
Sohn, H., Pai, M., Dendukuri, N., Kloda, L. A., Boehme, C. C., & Steingart, K. R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593 · Cited by 20
Metadata
- Authors
- Moure, R., Muñoz, L., Torres, M., Santin, M., Martín, R., & Alcaide, F.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2011-03
- Volume
- 49
- Issue
- 3
- Pages
- 1137-1139
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2155790306
- Cited by
- 165
- References
- 18
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.